Cost-effectiveness of drotrecogin alfa (activated) in treating severe sepsis in the UK

被引：0
|
作者：
Davies, A
Hutton, J
Ridley, S
Chinn, C
Barber, B
机构：
来源：
INTENSIVE CARE MEDICINE | 2002年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
623
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [31] Impact of the number of failed organs on the cost-effectiveness of drotrecogin alfa (activated)
    Betancourt, M
    McKinnon, PS
    Devlin, JW
    Kanji, S
    Bach, DS
    Massanari, RM
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 : S160 - S160
  • [32] The development of drotrecogin alfa (activated) for the treatment of severe sepsis
    Macias, WL
    Yan, SB
    Grinnell, BW
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (05): : 360 - 370
  • [33] Clinical trials in severe sepsis with drotrecogin alfa (activated)
    Pierre-François Laterre
    [J]. Critical Care, 11
  • [34] Readministration of drotrecogin alfa (activated) in an adult with severe sepsis
    Scipione, Marco R.
    Nogid, Boris
    Davanos, Evangelia
    DiGregorio, Robert V.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (18) : 1711 - 1715
  • [35] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Choi, Goda
    de Pont, Anne-Cornelie J. M.
    Schultz, Marcus J.
    [J]. CRITICAL CARE, 2006, 10 (04):
  • [36] Clinical trials in severe sepsis with drotrecogin alfa (activated)
    Laterre, Pierre-Francois
    [J]. CRITICAL CARE, 2007, 11 (Suppl 5):
  • [37] Hemorrhagic risk of (activated) drotrecogin alfa in severe sepsis
    Perrotin, D
    [J]. ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2003, 22 : 16 - 19
  • [38] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Goda Choi
    Anne-Cornélie JM de Pont
    Marcus J Schultz
    [J]. Critical Care, 10
  • [39] Comparing the cost-effectiveness of drotrecogin alfa (activated) across three European countries
    Neilson, AR
    Schneider, H
    Finnern, HW
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 : S93 - S93
  • [40] Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression
    Kalil, Andre C.
    LaRosa, Steven P.
    [J]. LANCET INFECTIOUS DISEASES, 2012, 12 (09): : 678 - 686
12345